Δευτέρα 11 Μαρτίου 2024

3rd Greek Fashion Show with Vassilis Zoulias Featuring Soprano Soula Parassidis

 


3rd Greek Fashion Show with Vassilis Zoulias

And Pericles Kondylatos

Featuring

Opera soprano and cancer survivor Soula Parassidis

 

 

The internationally renowned Greek designer, Vassilis Zoulias, has been selected by the Lyceum of Greek Women of Montreal (LGWM) to present his summer creations at their 3rd Annual Greek Fashion Show in Montreal, this April 16th, in support of the project for the very early diagnosis of ovarian and endometrial cancer, the “DOvEEgene.”

 "I am thrilled that, through my work, I can contribute to such important medical research that has the potential to spare millions of women from ovarian cancer, this insidious disease known as the "silent killer.” I commend the LGWM for taking the lead in disseminating the DOvEEgene research and supporting it financially while promoting Greek fashion at the same time," said Vassilis Zoulias.

 

The fashion show will also showcase the talent of the well known jewelry designer, Pericles Kondylatos, who will present his latest collection inspired by his love of nature.



The spectacle will be highlighted by the presence of Zoulias’ muse, internationally acclaimed Canadian soprano, Soula Parassidis, who is a cancer survivor herself and who will strut the catwalk in a special Zoulias’ gown created expressly for the evening's live auction.

 Ambassador Robert Peck and his wife, Maria Pantazi, will be the honorary hosts of the event which will be co-ordinated by philanthropist Maria Fotopoulos.

Mr. Peck, the former Canadian ambassador to Greece, noted that "it is a pleasure to serve, alongside my spouse Maria, as honorary co-chair, of this fashion show in support of the DOvEEGene project that has shown great promise for the very early detection of ovarian and endometrial cancer.”

“We admire both the mission and philanthropic endeavours of the LGWM and would like to recognize the generous support of the Greek fashion icon, Vasilios Zoulias. The participation of his friend and collaborator, Soula Parassidis, will be memorable indeed."

 Five women, THE FABULOUS FIVE, who have survived ovarian and breast cancer will also walk the runway: They are Amalia Markakis, Yula Kiskiras, Ioanna Photiadis, Sheyda Senoglou, Josée Barbe.

Justine Fragouli-Argyris, president of the LGWM, stated that “we, the Greeks of Canada, are grateful to the two renowned Greek designers, Vassilis Zoulias and Pericles Kondylatos, for their participation in this event in support of the DOvEEgene. a pioneering molecular detection test whose dissemination and universal acceptance by the medical community will help save future generations of women from ovarian and endometrial cancer.”

“At the same time, we will be showcasing acclaimed Greek fashion and I am very proud that the LGWM is in the forefront of the promotion of Greek creativity abroad.”

 “This year we are blessed to have the participation of world class soprano, Soula Parassidis, who will both highlight the allure of Greek fashion as well as the storied history of Greek opera by enchanting us with an aria or two sung by Maria Callas."

The Doveegene Project



Dr. Lucy Gilbert is in the final stages of the clinical research for the new molecular “Pap-type” test that will detect ovarian and endometrial cancer very early. Many LGWM female members have already taken the test and two were diagnosed with pre-cancerous cells in their abdomen and underwent hysterectomy, saving them from the silent killer that is ovarian cancer.

 While many researchers are working on ovarian and endometrial cancers, Dr. Gilbert is the only local researcher looking for an early detection test. She is uniquely positioned to achieve this goal. While labs in the US may have more funding, her expertise as a physician and her access to a diversity of women within our public healthcare system are key to enabling her to finish the clinical study needed to confirm her discovery. This is historical and it is happening right here, in Montreal! 

 

About the Lyceum of Greek Women of Montreal (LGWM)

 


The Lyceum of Greek Women of Montreal is a foundation registered with CRA, a non profit organization that promotes cultural and feminist issues among its other activities.

 The 15 women from various professions and backgrounds who comprise the board of directors of the LGWM are Canadian ladies of Hellenic origin with passion and dedication to various causes. From its creation in 2016, the LGWM has promoted unique aspects of Greek culture beginning with their first major undertaking, the “STATUE OF THE GREEK IMMIGRANT,” a work by the esteemed international sculptor, Giorgos Houliaras, that was donated to the City of Montreal on the occasion of its 375th anniversary and has become one of the city’s major landmarks.

 With numerous successful events to its credit, the LGWM has been a major force behind the research of the DOvEEgene Project being carried out by Dr. Lucy Gilbert's team at McGill University and which will soon become the (new) tool for the prevention of ovarian and endometrial cancer. 

 Although its roots derive from traditional Hellenic culture, the LGWM has influenced and continues to influence Montreal’s macro-culture, leaving its mark on the modern cultural landscape of the city.

 

 

A letter from Dr. Lucy Gilbert 

 

Dear Friends and Well-Wishers,

 

On behalf of my clinical and research team and all the women whose lives you have positively impacted, I would like to thank the Lyceum of Greek Women of Montreal and the Greek community at large for your wholehearted and generous support of the DOvEEgene project to Detect Ovarian and Endometrial cancers Early using a genomic pap test.

 This genomic pap test is the only one of its kind in the world to be undergoing Phase 3  clinical trial testing in healthy women. We began the clinical trial in May 2021, and, to date, we have tested 2736 of the 3600 women we intend to test. So far, we have identified 27 cancers. The test also identifies women who are carrying a hereditary mutation that substantially increases their risk of ovarian and breast cancer. As such, the DOvEEgene test identifies current cancer as well as future risk. No other test does this. The results have far exceeded our expectations. Buoyed by your generous support and the fact that even small improvements have profound consequences, we continue to make refinements to the test. 

 The very first screening test for women’s cancers--the pap test invented by a Greek Physician, Dr George Papanicolaou--has saved millions of lives.  It has driven cervical cancer from the 2nd leading cause of cancer deaths among Canadian women to 14th place.

 Ovarian and endometrial cancer is currently the third most common cause of cancer deaths in Canadian women. Your help has been crucial in allowing us to get the DOvEEgene trial off the ground and your continued support will help us make this test part of routine preventive health care for women.

 Thank you from the bottom of my heart.

 

Lucy Gilbert, MD, Chair, Gerald Bronfman Department of Oncology (GBDO), Faculty of Medicine and Health Sciences (FMHS), McGill University

MD MSc FRCOG

Director, MUHC Gynecologic Oncology Division

McGill University Health Care